Eculizumab

Eculizumab (INN and USAN; trade name Soliris) is a humanized monoclonal antibody that is a terminal complement inhibitor. In people with paroxysmal nocturnal hemoglobinuria (PNH) it improves quality of life but does not appear to affect the risk of death. Its safety is unclear as of 2014. It is the first approved therapy for paroxysmal nocturnal hemoglobinuria. Eculizumab is also the first agent approved treatment of atypical hemolytic uremic syndrome (aHUS) with likely benefit based on two small trials.

单词	Eculizumab
释义	Eculizumab 英语百科 Eculizumab Eculizumab (INN and USAN; trade name Soliris) is a humanized monoclonal antibody that is a terminal complement inhibitor. In people with paroxysmal nocturnal hemoglobinuria (PNH) it improves quality of life but does not appear to affect the risk of death. Its safety is unclear as of 2014. It is the first approved therapy for paroxysmal nocturnal hemoglobinuria. Eculizumab is also the first agent approved treatment of atypical hemolytic uremic syndrome (aHUS) with likely benefit based on two small trials.
随便看	Baruch, Bernard Mannes Baruch circumcision scissors Baruch de Spinoza baruch de spinozas baruchel Baruch Hashem Baruch law Baruchowo Baruch Plan Baruch sign Baruga Barugo Baruipur barukhzy Barulho Barum Barumini Barun bar underframe Barundi barunduki barundukis Barunga Barun Gl. Barung, Nusa